In support of this assessment, lower levels of BIM (BCL2L11) gene expression were found in ICBP breast cancer cell lines (p = 0.0004) and TCGA tumors (p = 0.0002), and RPPA protein expression was lower in TCGA tumors (p < 0.0001) (Fig. 4d). Here, BCL2L11 is linked to breast carcinoma.